Who manages commercial data governance for pharma companies in South Africa?
We build and run commercial data governance for pharmaceutical companies in South Africa. Every customer, sales and territory record has an owner, and every change is proposed, approved and recorded. For a pharmaceutical distribution group, we reviewed data governance in a diagnostic and took on interim data processing under a signed memorandum. We are POPIA-bound and pursuing ISO/IEC 27001.
What does commercial data governance cover?
Commercial data governance covers the data a pharmaceutical sales operation calculates from: the customer master, sales history, territory structure and rep ownership. We put defined ownership, change control and an audit trail over that data. Records move through controlled states, from draft to approved to active to superseded. A customer is not reclassified on a whim, and a territory boundary does not move silently: the change is proposed, approved and recorded with its reason. When a target is questioned at year-end, the data it was built on can be traced back to what was true when the target was set. The work is described on the Commercial Data Management service page.
How is the data kept confidential?
Need-to-know access is the default. Customer and commercial data is structured with access controls and consent handling built in from the start, not retrofitted. We are POPIA-bound and pursuing certification to ISO/IEC 27001 and ISO/IEC 42001, and our POPIA registration, 2026-001668, is listed on our About page. Data is kept isolated between clients and between sources, and your data stays in your engagement. Where another provider’s data is combined with yours, each source is integrated within its contractual boundaries, as the Data Fusion Intelligence methodology sets out.
Where has this been done for a pharmaceutical business?
For a pharmaceutical distribution holding group, we ran an independent diagnostic of its data foundation that included a governance review, one of four areas alongside data quality, master data and system integration. While the findings were assessed, we took on interim data processing for the group under a signed memorandum, so its operational data handling continued. The group is anonymous and the engagement started in July 2026. The detail is in the case study.
When is it not the right fit?
It is not the right fit while the reason your numbers are not trusted is still unclear. A diagnosis comes first, and how we diagnose commercial data problems explains what it examines. It is also not the right fit if the data is to stay spread across spreadsheets. Governance here runs on one relational structure that holds the customer master, sales history, territory structure and rep ownership together, so a change in one place flows through everywhere. That foundation sits underneath our territory, target and incentive work; you can start with it, or we build it as part of a wider engagement.
Frequently asked questions
What does commercial data governance mean in practice?
It means defined ownership, change control and an audit trail over customer, sales and territory data. Records move from draft to approved to active to superseded, so a reclassification or a boundary change is proposed, approved and recorded, never made quietly.
Why does commercial data need governing at all?
Because every downstream decision inherits its errors. A duplicate customer record splits one account's sales across two lines and understates a territory, and an account nobody owns goes unvisited. Targets, routes and incentives are no more trustworthy than the customer and sales data they are calculated from.
Is the approach POPIA-aligned?
Yes. Need-to-know access is the default, and access controls and consent handling are built in from the start. We are POPIA-bound and pursuing certification to ISO/IEC 27001 and ISO/IEC 42001.
Is our data kept separate from other clients' data?
Yes. We keep data isolated between clients and between sources, and your data stays in your engagement. Where another provider's data is combined with yours, it is integrated within that provider's contractual boundaries.
Can data operations continue while the foundation is reviewed?
Yes. For a pharmaceutical distribution group, we took on interim data processing under a signed memorandum alongside the diagnostic, so operational data handling continued while the findings were assessed. The group is anonymous.